Pliant shareholders re-elect directors, approve say-on-pay at 2022 annual meeting

PLIANT THERAPEUTICS, INC.

Shareholders elected John Curnutte (22.7M for) and Smital Shah (22.7M for) as Class II directors.
Advisory vote on named executive officer compensation passed with 27.9M for, 111.6K against.
Advisory vote on frequency of future say-on-pay approved with 28.0M favoring one-year interval.
Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 34.1M for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.